Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

725 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of a Prasugrel- vs. a Ticagrelor-based strategy on total ischaemic and bleeding events in patients with acute coronary syndromes.
Aytekin A, Coughlan JJ, Ndrepepa G, Cassese S, Lahu S, Kufner S, Mayer K, Xhepa E, Gewalt S, Joner M, Hapfelmeier A, Angiolillo DJ, Menichelli M, Richardt G, Neumann FJ, Schunkert H, Kastrati A. Aytekin A, et al. Among authors: angiolillo dj. Eur Heart J Cardiovasc Pharmacother. 2023 Apr 10;9(3):231-239. doi: 10.1093/ehjcvp/pvac067. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 36434779 Clinical Trial.
Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial.
Spirito A, Kastrati A, Cao D, Baber U, Sartori S, Angiolillo DJ, Briguori C, Cohen DJ, Dangas G, Dudek D, Escaned J, Gibson CM, Zhang Z, Huber K, Kaul U, Kornowski R, Kunadian V, Han YL, Mehta SR, Sardella G, Sharma S, Shlofmitz RA, Vogel B, Collier T, Pocock S, Mehran R. Spirito A, et al. Among authors: angiolillo dj. Eur Heart J Cardiovasc Pharmacother. 2023 Jun 2;9(4):328-336. doi: 10.1093/ehjcvp/pvad006. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 36649694 Clinical Trial.
Ticagrelor enhances the cardioprotective effects of ischemic preconditioning in stable patients undergoing percutaneous coronary intervention: the TAPER-S randomized study.
D'Amario D, Galli M, Restivo A, Canonico F, Vergallo R, Migliaro S, Trani C, Burzotta F, Aurigemma C, Laborante R, Romagnoli E, Francese F, Ceccarelli I, Borovac JA, Angiolillo DJ, Tavazzi B, Leone AM, Crea F, Patti G, Porto I. D'Amario D, et al. Among authors: angiolillo dj. Eur Heart J Cardiovasc Pharmacother. 2024 May 4;10(3):190-200. doi: 10.1093/ehjcvp/pvad092. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38006237 Clinical Trial.
Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel.
Aytekin A, Scalamogna M, Coughlan JJ, Lahu S, Ndrepepa G, Menichelli M, Mayer K, Wöhrle J, Bernlochner I, Witzenbichler B, Hochholzer W, Sibbing D, Angiolillo DJ, Hemetsberger R, Tölg R, Valina C, Müller A, Kufner S, Liebetrau C, Xhepa E, Hapfelmeier A, Sager HB, Joner M, Richardt G, Laugwitz KL, Neumann FJ, Schunkert H, Schüpke S, Kastrati A, Cassese S. Aytekin A, et al. Among authors: angiolillo dj. Clin Res Cardiol. 2024 Jul;113(7):1060-1069. doi: 10.1007/s00392-024-02454-x. Epub 2024 May 13. Clin Res Cardiol. 2024. PMID: 38740722 Free PMC article. Clinical Trial.
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease.
Valgimigli M, Aboyans V, Angiolillo D, Atar D, Capodanno D, Halvorsen S, James S, Jüni P, Kunadian V, Landi A, Leonardi S, Mehran R, Montalescot G, Navarese EP, Niebauer J, Oliva A, Piccolo R, Price S, Storey RF, Völler H, Vranckx P, Windecker S, Fox KAA. Valgimigli M, et al. Eur Heart J Cardiovasc Pharmacother. 2023 Jul 29;9(5):462-496. doi: 10.1093/ehjcvp/pvad032. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 37120728 Free article.
External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis.
Munafò AR, Montalto C, Franzino M, Pistelli L, Di Bella G, Ferlini M, Leonardi S, D'Ascenzo F, Gragnano F, Oreglia JA, Oliva F, Ortega-Paz L, Calabrò P, Angiolillo DJ, Valgimigli M, Micari A, Costa F. Munafò AR, et al. Among authors: angiolillo dj. Eur Heart J Cardiovasc Pharmacother. 2023 Dec 14;9(8):709-721. doi: 10.1093/ehjcvp/pvad063. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 37634083
Aspirin hypersensitivity and intolerance.
Galli M, Occhipinti G, Angiolillo DJ. Galli M, et al. Among authors: angiolillo dj. Eur Heart J Cardiovasc Pharmacother. 2024 May 4;10(3):173-174. doi: 10.1093/ehjcvp/pvae008. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38268418 No abstract available.
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis.
Galli M, Occhipinti G, Benenati S, Laborante R, Ortega-Paz L, Franchi F, D'Amario D, Nerla R, Castriota F, Frati G, Biondi-Zoccai G, Sciarretta S, Angiolillo DJ. Galli M, et al. Among authors: angiolillo dj. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 4;10(6):526-536. doi: 10.1093/ehjcvp/pvae036. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38754988
725 results